Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. Continue reading
Author Archive: AZBio
We’re Hiring – Molecular Technologist at PinPoint Clinical
Seeking Molecular Technologist for full time position with Pharmacogenomic processing experience
Continue reading
CRITICAL PATH INSTITUTE SECURES REGULATORY SUPPORT FOR SKELETAL MUSCLE SAFETY BIOMARKERS
FDA and EMA Letters of Support Suggest Valuable Research PotentialContinue reading
UA Vet Med Program Looks at Needs
By Gabrielle Fimbres, College of Agriculture and Life Sciences | April 8, 2015Continue reading
AMCG standards in genomic variations
News Brief for AZBio MembersContinue reading
TGen scientists find likely genetic source of muscle weakness in six previously undiagnosed children
Simple genetic test by TGen reveals likely causes of disease, after other extensive testing failed; one child’s case produces discoveryContinue reading
Ducey signs legislation to allow lab testing without a doctor’s order
By: Howard Fischer, Capitol Media Services April 7, 2015 , 6:00 am (Republished with permission.)
Arizonans who want to want to run their own lab tests will soon be able to do so without first visiting a doctor.
But your insurance company won’t pick up the tab.
Hoya Group Invests in SalutarisMD Wet AMD Therapy Technology
HOYA Group has closed financing in Salutaris Medical Devices (SalutarisMD®). SalutarisMD will use the funding to further its growth strategy in developing its patented medical device designed for minimally invasive therapy of wet age-related macular degeneration (wet AMD). Wet AMD is a leading cause of vision loss and blindness that primarily affects older adults.
Flagship Biosciences reaches milestone with “fit-for-purpose” digital pathology services
Flagship Biosciences’ completes its 400th study with tissue image analysis, and fit-for-purpose IHC and ISH assay development
Continue reading
